Development and Evaluation of a Candidate Inactivated Vaccine Against Bluetongue Virus Serotype 4 (BTV4)
Objectives: Although bluetongue is not a contagious disease, it is easily transmitted and spread by appropriate insect vectors, causing great economic damage. Climate change has led to the fact that vectors and diseases have spread to the top of Northern Europe, causing great economic losses in live...
Saved in:
| Main Authors: | Ljubisa Veljovic, Dimitrije Glisic, Marko Kirovski, Ljiljana Paušak, Vesna Milicevic |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/12/12/1326 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cases of detection of serotype 14 bluetongue vaccine-like virus in the RF and European countries in 2011-2012
by: V. M. Zakharov, et al.
Published: (2018-04-01) -
Comparison of Inactivated and Oral Poliovirus Vaccines
by: Hüseyin Anıl Korkmaz, et al.
Published: (2013-04-01) -
In Silico Development of a Multi-Epitope Subunit Vaccine against Bluetongue Virus in <i>Ovis aries</i> Using Immunoinformatics
by: Priyansha Raj Sinha, et al.
Published: (2024-10-01) -
Exceptional Bluetongue virus (BTV) and Epizootic hemorrhagic disease virus (EHDV) circulation in France in 2023
by: Mathilde Gondard, et al.
Published: (2024-12-01) -
Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine
by: Viravarn Luvira, et al.
Published: (2024-12-01)